Cargando…

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review

Background: Depression is a debilitating disease with a high socioeconomic burden. Regular antidepressants usually require several weeks to ameliorate symptoms; however, numerous patients do not achieve remission. What is more, sleep disturbances are one of the most common residual symptoms. Ketamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwaśny, Aleksander, Włodarczyk, Adam, Ogonowski, Damian, Cubała, Wiesław Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143949/ https://www.ncbi.nlm.nih.gov/pubmed/37111325 http://dx.doi.org/10.3390/ph16040568

Ejemplares similares

Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Residual insomnia in major depressive disorder: a systematic review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2020)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
por: Wilkowska, Alina, et al.
Publicado: (2022)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Dietary Patterns of Treatment–Resistant Depression Patients
por: Mechlińska, Agnieszka, et al.
Publicado: (2022)

Gut Microbiota in Depression: A Focus on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2021)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
por: Wichniak, Adam, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Ketamine in Bipolar Disorder: A Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2023)

Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
por: Szałach, Łukasz Piotr, et al.
Publicado: (2022)

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2014)

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023)

Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Alshahrani, Mohammed S., et al.
Publicado: (2021)

Sleep deprivation as treatment for depression: Systematic review and meta‐analysis
por: Ioannou, Michael, et al.
Publicado: (2020)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Sleep Treatments in Disorders of Consciousness: A Systematic Review
por: Cacciatore, Martina, et al.
Publicado: (2021)

Heart rate variability and incidence of depression during the first six months following first myocardial infarction
por: Wilkowska, Alina, et al.
Publicado: (2019)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Etomidate Compared to Ketamine for Induction during Rapid Sequence Intubation: A Systematic Review and Meta-analysis
por: Sharda, Saurabh C, et al.
Publicado: (2022)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Efficacy and safety of perioperative application of ketamine on postoperative depression: A meta-analysis of randomized controlled studies
por: Guo, Jie, et al.
Publicado: (2023)

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
por: Mechlińska, Agnieszka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t9r1jnh4bbaotvk204h0d9u6r6